Cell Cycle Aberration in Ameloblastoma: as Evidenced by an Immunohistochemical Expression of P53 and Survivin

Dr. Zulfin Shaikh
Dr. Zulfin Shaikh
Dr. Niranjan K C
Dr. Niranjan K C
Rajiv Gandhi University of Health Sciences

Send Message

To: Author

Cell Cycle Aberration in Ameloblastoma: as Evidenced by an Immunohistochemical Expression  of P53 and Survivin

Article Fingerprint

ReserarchID

3HCLP

Cell Cycle Aberration in Ameloblastoma: as Evidenced by an Immunohistochemical Expression  of P53 and Survivin Banner

AI TAKEAWAY

Connecting with the Eternal Ground
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu
Font Type
Font Size
Font Size
Bedground

Abstract

Evasion from apoptosis by aberrations of apoptotic regulatory factors has been found to cause accumulation of neoplastic cells in various tumours. Survivin, an inhibitor of apoptosis protein localizes to the nucleus as well as in the cytoplasm depending on its function such as cell division and inhibiting apoptosis. The regulation of Survivin seems to be linked to p53, a tumour suppressor gene. Though there are studies showing the role of p53 and Survivin in oral carcinogenesis, but the field of odontogenic tumours yet needs to be explored. The aim of this study was to correlate the expression of p53 and Survivin in normal tissues (tooth germ) and Ameloblastoma as well as to assess differential localization of Survivin. Qualitative and quantitative assess-ment of immunexpression of p53 and Survivin (nuclear and cytoplasmic) was evaluated in a total of 35 cases which included 10 tooth germs and 25 Ameloblastoma. The expression levels of p53 and nuclear Survivin were significantly higher in Ameloblastoma quantitatively but there was no significant correlation between p53 and cytoplasmic expression of Survivin.

References

38 Cites in Article
  1. Hiroyuki Kumamoto (2010). Molecular alterations in the development and progression of odontogenic tumors.
  2. H Kumamoto (2006). Molecular pathology of odontogenic tumors.
  3. H Philipsen (1998). Cell Cycle Aberration in Ameloblastoma: As Evidenced by an Immunohistochemical Expression of p53 and Survivin" survivin.
  4. Carl Miller,T Mohandas,D Wolf,M Prokocimer,V Rotter,H Phillip Koeffler (1986). Human p53 gene localized to short arm of chromosome 17.
  5. L Loro,O Vintermyr,A Johannessen (2005). Apoptosis in normal and diseased oral tissues.
  6. Y Shi (2000). Survivin structure: crystal unclear.
  7. Dario Altieri (2006). The case for survivin as a regulator of microtubule dynamics and cell-death decisions.
  8. Shirley Knauer,Wolf Mann,Roland Stauber (2007). Survivin’s Dual Role: An Export’s View.
  9. Roland Stauber,Wolf Mann,Shirley Knauer (2007). Nuclear and Cytoplasmic Survivin: Molecular Mechanism, Prognostic, and Therapeutic Potential.
  10. Shirley Knauer,Oliver Krämer,Thomas Knösel,Knut Engels,Franz Rödel,Adorján Kovács,Wolfgang Dietmaier,Ludger Klein‐hitpass,Negusse Habtemichael,Andrea Schweitzer,Jürgen Brieger,Claus Rödel,Wolf Mann,Iver Petersen,Thorsten Heinzel,Roland Stauber (2007). Nuclear export is essential for the tumor‐promoting activity of survivin.
  11. G Qi,H Tuncel,E Aoki (2009). Intracellular localization of survivin determines biological behavior in colorectal cancer.
  12. Fengzhi Li,Jie Yang,Nithya Ramnath,Milind Javle,Dongfeng Tan (2005). Nuclear or cytoplasmic expression of survivin: What is the significance?.
  13. Asra Mirza,Marnie Mcguirk,Tish Hockenberry,Qun Wu,Hena Ashar,Stuart Black,Shu Wen,Luquan Wang,Paul Kirschmeier,W Bishop,Loretta Nielsen,Cecil Pickett,Suxing Liu (2002). Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway.
  14. G Lo Muzio,Pannone,Staibano (2003). Survivin expression in oral squamous cell carcinoma.
  15. Ping Chen,Jian Li,Li‐ping Ge,Chun‐hua Dai,Xiao‐qin Li (2010). Prognostic value of survivin, X‐linked inhibitor of apoptosis protein and second mitochondria‐derived activator of caspases expression in advanced non‐small‐cell lung cancer patients.
  16. J Choi,H Chang (2012). The expression of MAGE and SSX, and correlation of COX2, VEGF, and survivin in colorectal cancer.
  17. Aziza Nassar,Debbie Sexton,George Cotsonis,Cynthia Cohen (2008). Survivin Expression in Breast Carcinoma: Correlation With Apoptosis and Prognosis.
  18. J Kim,J Chung,S Lee (2006). Nuclear interaction of Smac/DIABLO with Survivin at G2/M arrest prompts docetaxel-induced apoptosis in DU145 prostate cancer cells.
  19. Takeshi Ito,Katsuya Shiraki,Kazushi Sugimoto,Takenari Yamanaka,Katsuhiko Fujikawa,Masaaki Ito,Koujiro Takase,Masami Moriyama,Hirokazu Kawano,Midori Hayashida,Takeshi Nakano,Atsushi Suzuki (2000). Survivin promotes cell proliferation in human hepatocellular carcinoma.
  20. Carlos Barboza,Leão Pinto,Roseana Freitas,Antônio Costa,Lélia Souza (2005). Proliferating cell nuclear antigen (PCNA) and p53 protein expression in ameloblastoma and adenomatoid adontogenic tumor.
  21. J Carvalhais,De Aguiar,V De Araujo (1995). P53 and MDM2 expression in odontogenic cysts and tumours.
  22. Susanne Lens,Gerben Vader,René Medema (2006). The case for Survivin as mitotic regulator.
  23. Shirley Knauer,Carolin Bier,Negusse Habtemichael,Roland Stauber (2006). The Survivin–Crm1 interaction is essential for chromosomal passenger complex localization and function.
  24. F Li (2005). Role of surviving and its splice variants in tumorigenesis.
  25. Anna Parenti,Genesio Leo,Andrea Porzionato,Giovanni Zaninotto,Antonio Rosato,Vito Ninfo (2006). Expression of survivin, p53, and caspase 3 in Barrett's esophagus carcinogenesis.
  26. Marian Adamkov,Erika Halasova,Julius Rajcani,Marian Bencat,Desanka Vybohova,Silvia Rybarova,Stefan Galbavy (2011). Relation between expression pattern of p53 and survivin in cutaneous basal cell carcinomas.
  27. K Ranade,A Nerurkar,M Phulpagar (2009). Expression of Survivin and p53 proteins and their correlation with hormone receptor status in Indian breast cancer patients.
  28. E Halasova,M Adamkov,E Kavcova (2009). Expression of anti-apoptotic protein survivin and tumor suppressor p53 protein in patients with pulmonary carcinoma.
  29. N El-Sissy (1999). Immunohistochemical detection of p53 protein in ameloblastoma types.
  30. K Al-Salihi,L Li,A ; Azlina,R Stauber,W Mann,S Knauer (2006). Cell Cycle Aberration in Ameloblastoma: As Evidenced by an Immunohistochemical Expression of p53 and Survivin.
  31. Michiko Shintani,Akiko Sangawa,Naoki Yamao,Shingo Kamoshida (2013). Smac/DIABLO expression in human gastrointestinal carcinoma: Association with clinicopathological parameters and survivin expression.
  32. Márcia De Oliveira,Isabel Da Silva Lauxen,Anna Chaves,Pantelis Rados,Manoel Sant’ana Filho (2010). Odontogenic Epithelium: Immunolabeling of Ki-67, EGFR and Survivin in Pericoronal Follicles, Dentigerous Cysts and Keratocystic Odontogenic Tumors.
  33. Hiroyuki Kumamoto,Kiyoshi Ooya (2004). Expression of survivin and X chromosome-linked inhibitor of apoptosis protein in ameloblastomas.
  34. M Andric,B Dozic,B Popovic (2010). Survivin expression in odontogenic keratocysts and correlation with cytomegalovirus infection.
  35. Monica Hollstein,David Sidransky,Bert Vogelstein,Curtis Harris (1991). p53 Mutations in Human Cancers.
  36. Al-Fayad Dws (2010). Immunohistochemical Expression of P53 in Different Types of Ameloblastoma.
  37. L Bai,W Zhu (2006). p53: Structure, Function and Therapeutic Applications.
  38. Dario Altieri (2003). Survivin, versatile modulation of cell division and apoptosis in cancer.

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Dr. Zulfin Shaikh. 2014. \u201cCell Cycle Aberration in Ameloblastoma: as Evidenced by an Immunohistochemical Expression of P53 and Survivin\u201d. Global Journal of Medical Research - J: Dentistry & Otolaryngology GJMR-J Volume 14 (GJMR Volume 14 Issue J6).

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Version of record

v1.2

Issue date
December 25, 2014

Language
en
Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

Article Matrices
Total Views: 4435
Total Downloads: 2124
2026 Trends
Related Research
Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

Quote and Order Details

Contact Person

Invoice Address

Notes or Comments

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

Cell Cycle Aberration in Ameloblastoma: as Evidenced by an Immunohistochemical Expression of P53 and Survivin

Dr. Zulfin Shaikh
Dr. Zulfin Shaikh <p>Rajiv Gandhi University of Health Sciences</p>
Dr. Niranjan K C
Dr. Niranjan K C

Research Journals